Searched for
NEW MOLECULAR ENTITIES
88% ‘hard-to-recycle’ plastic: PolyCycl’s bet on turning waste into valueIndia's plastic waste problem is being tackled by PolyCycl's innovative chemical recycling. The technology transforms difficult-to-recycle ...- DeepMind scientist calls LLMs 'exotic mind-like entities': Why the future of AI needs a new vocabulary?DeepMind Principal Scientist Murray Shanahan describes large language models (LLMs) as "exotic mind-like entities," highlighting our lack o...
- Pharma CMOs may feel heat as USFDA approves fewer new drugs, GlobalData report saysInflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, stated GlobalData in its latest ...
- Neuberg may file IPO papers in H2 of FY23Besides chairman GSK Velu, the other founding members of Neuberg Diagnostics are Anand Diagnostic Laboratory (Bengaluru), Supratech Micropa...
- CSIR-CCMB, Apollo Hospitals to jointly produce, commercialise COVID-19 test kitsThe rapid DArRT-PCR tests, which allows for rapid, safer and more cost-effective SARS-COV-2 testing, will be available nationally through t...
- Glenmark eyes 15% sales growth over 3-5 yearsGlenmark is targeting a consolidated revenue growth of 12-15 per cent over the next 3-5 years.
- Eyeing over 80% sales from US, India, Europe by 2021: GlenmarkAs part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentatio...
- India may be first to go for simplified TB treatment plan"TB remains a significant challenge in India, killing approximately half a million-people in 2015 alone," said Anil Koul director, CSIR-IMT...
- Glenmark Pharma draws up capex of USD 300 mn over next 3 yearsGlenmark along with its subsidiaries operate 17 manufacturing facilities across four countries and has five research and development center...
- Glenmark working on proprietary product rolloutThe company plans to build a global manufacturing footprint, increase presence in complex generics, launching of specialty business in the ...
- Syngene to invest $100 mn for new plant in Mangalore SEZSyngene International, contract research arm of biotechnology major Biocon is planning to set up a new manufacturing plant in Mangalore wit...
- Top brokers recommend 'subscribe' to Syngene International IPO; here's whyLong-term investors should 'subscribe' to Syngene IPO which opens for subscription today, various brokerages said in a report.
- Syngene IPO money to fund Biocon research: ShawShaw said that Biocon has the largest biosimilar pipeline globally in phase three clinical trials and the IPO will help fund those costs.
- Cancer Genetics Inc completes BioServe India buyCancer Genetics Inc has on Monday announced completing the acquisition of the Hyderabad-based genomic services firm BioServe India which is...
- Symposium on new drug discovery begins at Zydus Research CentreThe symposium is to address various aspects related to new drug discovery with a focus on cancer, inflammation, cardiometabolic diseases an...
- Piramal Enterprises Q1 net profit at Rs 4.08 croreDiversified company Piramal Enterprises today reported a consolidated net profit of Rs 4.08 crore for the quarter ended June 30, 2012.
- Glenmark eyes 20% sales growth in India speciality business in 3 yearsGlenmark Pharmaceuticals expects sales of its speciality business, which focuses on branded products, to grow by around 20 per cent in Indi...
- Abbott to acquire Solvay Pharmaceuticals for $ 6.6 bnUS healthcare major Abbott Laboratories will buy pharma business of Belgium-based Solvay Group for USD 6.6 billion.
- Cadila files new drug application; share up nearly 1%Cadila Healthcare has filed an investigational new drug application for conducting clinical trials for molecular entity - ZYH7, to treat dy...
- Sop for non-critical diagnostic kit importThe government has decided to free exporters of non-critical diagnostic kits into the country from payment of import registration fee.
Load More
